Furthermore, it enhances the validity and reduces potential bias
The findings, published in the journal Nature Medicine, suggest the drug may tackle food cravings by affecting the brain signal biomarkers associated with eating control
A little background: In May 2025, Novo Nordisk, the maker of Rybelsus, Wegovy, and Ozempic, applied for FDA approval of an oral version of Wegovy
However, since the May date, many compound pharmacies are still producing and offering Semaglutide, but that may change in the future
As these therapies reshape treatment approaches for obesity and potentially a range of other chronic conditions, theyre also prompting questions about access, long-term outcomes, and the future of innovation in chronic disease care
Every plan is custom-designed to fit your specific goals, medical history, and lifestyle